Sign in

Kristoffer Stewart

@journal-kristoffer.bsky.social
769 followers 1.9K following 25 posts

Clinical editor at BMJ Oncology & BMJ Immunology Pharmacist turned editor he/his #ClinicalEditor #Oncology #Immunology

PostsRepliesMedia
Reposted by Kristoffer Stewart
Wafik S. El-Deiry, MD, PhD, FACP @weldeiry.bsky.social · 29/11/2025
KRAS-targeted therapies in cancer: novel approaches and overcoming resistance bmjoncology.bmj.com/content/4/1/...
bmjoncology.bmj.com
031
Kristoffer Stewart @journal-kristoffer.bsky.social · 05/11/2025
000
Kristoffer Stewart @journal-kristoffer.bsky.social · 17/10/2025
Excited to be at #esmo! Though there is so much on the agenda I don't know where to begin - suggestions are welcome! @myesmo.bsky.social
010
Reposted by Kristoffer Stewart
Kate Sears @katesears.bsky.social · 27/08/2025
✅ Highlights the urgent need for equity & global trial harmonization. ❓ Question to think: Should trial standards always reflect the best global care — or adapt to local realities? #OncoEthics #GlobalOncology #ClinicalTrials #OncoTwitter #Medicalwatch bmjoncology.bmj.com/content/4/1/...
bmjoncology.bmj.com
Inferior control arms in oncology trials in LMICs: contextualised or compromised?
In recent years, cancer drug randomised controlled trials (RCTs) have been criticised for employing a control arm treatment that is inferior or suboptimal to the existing standard of care.1 2 Using an...
121
Kristoffer Stewart @journal-kristoffer.bsky.social · 18/08/2025
Really excited to see this paper live on BMJ Oncology! The authors have provided a comprehensive overview of novel radiopharmaceuticals for molecular imaging of renal cell carcinoma🔬 bmjoncology.bmj.com/content/4/1/... #radiation #kidneycancer #oncology
bmjoncology.bmj.com
Novel radiopharmaceuticals for molecular imaging of renal cell carcinoma
Conventional diagnostic strategies for imaging patients with renal cell carcinoma (RCC) have predominantly relied on ultrasonography, CT and MRI. However, a paradigm shift is underway with the emergen...
020
Kristoffer Stewart @journal-kristoffer.bsky.social · 05/08/2025
Really excited to see this paper live on BMJ Oncology! The authors have provided a comprehensive overview of the tumour-infiltrating lymphocyte therapy landscape, and their work will be a valuable resource for the field 🔬 bmjoncology.bmj.com/content/4/1/... #immunotherapy #immunology #oncology
030
Kristoffer Stewart @journal-kristoffer.bsky.social · 19/07/2025
We're hiring a new clinical editor to join our team and support the launch of a new journal, BMJ Surgery Clinical Editor - BMJ Surgery £69,632 (pro-rata 0.4fte) London, Hybrid jobsearch.bmj.com/jobs/latest If you want to know more email kstewart@bmj.com
jobsearch.bmj.com
Jobs and careers with BMJ Group
Jobs and careers with BMJ Group -
010
Reposted by Kristoffer Stewart
Lisa MG, RN @lmg622.bsky.social · 10/06/2025
Significant gaps in testing for #lynchsyndrome #hereditarycancer risk, UK study finds @bmj.com #cancerresearch #oncsky #openaccess
bmjoncology.bmj.com
Mismatch in testing: a retrospective analysis of mismatch repair testing in endometrial cancer and Lynch syndrome diagnosis in multiple specialist centres in the UK and Ireland (March 2022–March 2023)
Objectives To assess the implementation of Lynch syndrome testing in endometrial cancer (EC) across the UK and Ireland, identify diagnostic gaps and evaluate adherence to the National Institute for He...
001
Kristoffer Stewart @journal-kristoffer.bsky.social · 06/06/2025
Can targeted therapies towards the hypoxia-inducible factor (HIF) pathway enhance the potency of current cancer treatments? This review explores the science: bmjoncology.bmj.com/content/3/1/... #cancer #hypoxia #oncology
bmjoncology.bmj.com
Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity
Cancer remains one of the most formidable challenges in modern medicine, due to its complex and dynamic nature, which demands innovative therapeutic approaches. One major challenge to cancer treatment...
010
Reposted by Kristoffer Stewart
Holly Fernandez Lynch @hollylynchez.bsky.social · 23/05/2025
New pub on cancer accelerated approvals in which we find: 1) PMR statements often lack specificity on key study design elements and 2) less stringent specs in PMR statements are associated with on-time submission, potentially trading rigor for speed. bmjoncology.bmj.com/content/4/1/...
bmjoncology.bmj.com
Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011–2023: a cross-sectiona...
Objectives To assess the specificity of postmarketing requirement (PMR) statements and associations between PMR statement specificity and PMR study characteristics, timeliness and regulatory decisions...
033
Kristoffer Stewart @journal-kristoffer.bsky.social · 25/04/2025
I'm wondering if I can get some help with the kind people of @bsky.app. I'm trying to compile a list of key conferences across the broad field of #immunology - if you have any thoughts please reply or directly message. All suggestions welcome!👍
010
Reposted by Kristoffer Stewart
Oncology Advocates United for Climate and Health International @ouchinternational.bsky.social · 04/04/2025
BMJ Oncology features research from OUCH members Dr. Roselle De Guzman & Dr. Joan Schiller on how pollutants contribute to cancer incidence and outcomes. Cleaner air isn't just an environmental issue; it's a public health necessity. Read more: bmjoncology.bmj.com/content/4/1/... #CancerResearch
bmjoncology.bmj.com
Air pollution and its impact on cancer incidence, cancer care and cancer outcomes
Air pollution is an under-recognised global health threat linked to an increased risk of cancers and is due primarily to the burning of fossil fuels. This review provides a high-level overview of the ...
012
Reposted by Kristoffer Stewart
Claire Poole @clairepoole.bsky.social · 12/02/2025
Innovations in #clinical #education - great opportunity to listen to ways to maximise learning for students across #healthcare #crtitical #thinking and #creative #arts. Don’t miss it 👇 @radchat.bsky.social @journal-kristoffer.bsky.social @yattsang.bsky.social @gerryhanna.bsky.social
053
Reposted by Kristoffer Stewart
Ananya Choudhury @achoud72.bsky.social · 01/02/2025
Happy PM day to all who celebrate! PubMed, that is. BMJ Oncology is proud to announce that all our content is now available on PubMed! 🎉 🍾 🥂 @journal-kristoffer.bsky.social @mazer.us @eabhalynn.bsky.social @oncoalert.bsky.social
1115
Kristoffer Stewart @journal-kristoffer.bsky.social · 03/12/2024
A study by Zhao et al. showed that since 1990, the incidence and deaths of early onset cancers have substantially increased globally🌍🌏🌍 Countries with a high-middle and middle Sociodemographic Index and individuals aged 40–49 years were particularly affected bmjoncology.bmj.com/content/2/1/...
bmjoncology.bmj.com
Global trends in incidence, death, burden and risk factors of early-onset cancer from 1990 to 2019
Objective This study aimed to explore the global burden of early-onset cancer based on the Global Burden of Disease (GBD) 2019 study for 29 cancers worldwid.Methods and analysis Incidence, deaths, dis...
161
Kristoffer Stewart @journal-kristoffer.bsky.social · 03/12/2024
I think this is great! If you want @bsky.app to continue to grow then give the big publishing bodies an excuse to back this app - share research and click on research. #research #oncology
030
Kristoffer Stewart @journal-kristoffer.bsky.social · 29/11/2024
This is a true testament to how I think this platform differs - I don't know this account, but just check out how wholesome it is as a concept 🥰 I look forward to following, committing to reading the book and inevitably letting everyone down 😅 @oncologybookclub.bsky.social @bsky.app
181
Kristoffer Stewart @journal-kristoffer.bsky.social · 28/11/2024
Flash backs to university when my friends who left their dissertation write-up and submission to the final minute and did better than me 😆
040
Kristoffer Stewart @journal-kristoffer.bsky.social · 28/11/2024
📣 Check out this recent study: UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study From @drmarkbaxter.bsky.social and colleagues: bmjoncology.bmj.com/content/3/1/... #cancer #chemotherapy
bmjoncology.bmj.com
UK national observational cohort study investigating Tolerance of Anti-cancer Systemic Therapy in the Elderly: the TOASTIE study
Objective The Cancer and Aging Research Group (CARG) score was developed to predict severe chemotherapy-induced toxicity risk in older adults; validation study results have varied. The Tolerance of An...
184
Reposted by Kristoffer Stewart
Nigel Praities @nigelpraities.bsky.social · 26/11/2024
We are working on a whole new set of courses on #palliativecare for BMJ Learning, starting with this one on pain management. If you want to know more, please contact: @journal-kristoffer.bsky.social
272
Kristoffer Stewart @journal-kristoffer.bsky.social · 22/11/2024
I clicked through into this special issue and nearly every article drew me in, such an interesting array of work. Give it a click this Friday afternoon and treat yourself to a bit of insight! 💻📱 Well done to all involved 👏
197
Kristoffer Stewart @journal-kristoffer.bsky.social · 20/11/2024
Are we overlooking cancer's hidden toxicities? 🧠Mental health strain 💰 Financial burdens ⏳ Logistical chaos Should addressing these be as routine as managing the tumor itself? #Oncology #CancerCare Check out this paper by BMJ ONC's patient advocate Rick Bangs: bmjoncology.bmj.com/content/3/1/...
BMJ Oncology - Patient toxicities
0104
Kristoffer Stewart @journal-kristoffer.bsky.social · 20/11/2024
Clinical endpoints (eg survival) measure real outcomes, but surrogate endpoints (eg tumor shrinkage) often fall short of predicting outcomes Can misuse of surrogates in trials harm patients? Are we too reliant on surrogates? bmjoncology.bmj.com/content/3/1/... @vinayprasadmdmph.bsky.social #Oncology
bmjoncology.bmj.com
Bedside implications of the use of surrogate endpoints in solid and haematological cancers: implications for our reliance on PFS, DFS, ORR, MRD and more
Clinical endpoints, such as overall survival, directly measure relevant outcomes. Surrogate endpoints, in contrast, are intermediate, stand-in measures of various tumour-related metrics and include tu...
031
Kristoffer Stewart @journal-kristoffer.bsky.social · 20/11/2024
Couldn't agree more!👏 The joy of not having to scroll past adverts, promoted content and boosted profiles on x! I'm excited to dive deeper and connect with those excited about sharing their ideas, work and enthusiasm!
030
Kristoffer Stewart @journal-kristoffer.bsky.social · 20/11/2024
Hi everyone! 👋 I'm new to #BSKY and want to connect with those working in the #oncology field. I'm the clinical editor for a new journal BMJ Oncology (bmjoncology.bmj.com). I want to connect with clinicians interested in discussing meaningful, applicable advances that benefit human #health🩺
bmjoncology.bmj.com
Homepage | BMJ Oncology
63510